Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias

The Metabolic and Molecular Bases of Inherited Disease

Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101

The metabolic and molecular bases of inherited disease

Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928

Common West African HLA antigens are associated with protection from severe malaria

Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D. P., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,573

Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria

McGuire, W. L., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. P. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,166

Pathogenesis and Treatment of Sickle Cell Disease

Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1×

The Thalassaemia Syndromes

Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,077

Messenger RNA degradation in eukaryotes

Sachs, A. B. (1993) · Cell · doi:10.1016/0092-8674(93)80043-e · Cited by 846

The Thalassæmia Syndromes.

(1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 808

Global prevalence of putative haemochromatosis mutations.

Merryweather‐Clarke, A. T., Pointon, J. J., Shearman, J. R., & Robson, K. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 781

The Molecular Basis of Blood Diseases.

(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 640

Sickle-cell disease

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504

The muscular dystrophies

Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667

β-Thalassemia

Rund, D. G., & Rachmilewitz, E. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 936

Understanding quantitative genetic variation

Barton, N., & Keightley, P. D. (2002) · Nature Reviews Genetics · doi:10.1038/nrg700 · Cited by 833

Beta-thalassemia

Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722

Identifying Signatures of Natural Selection in Tibetan and Andean Populations Using Dense Genome Scan Data

Bigham, A., Bauchet, M., Pinto, D., Mao, X., Akey, J. M., Mei, R., Scherer, S. W., Julian, C. G., Wilson, M. J., López Herráez, D., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001116 · Cited by 597

L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480

Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease

Esrick, E. B., Lehmann, L. E., Biffi, A., Achebe, M., Brendel, C., Ciuculescu, M. F., Daley, H., MacKinnon, B., Morris, E., Federico, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029392 · Cited by 449

Reactivation of developmentally silenced globin genes by forced chromatin looping

Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443

Genetics of susceptibitlity to human infectious disease

Cooke, G., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 447

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

Tanno, T., Porayette, P., Sripichai, O., Noh, S.-J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195503 · Cited by 352

Recombinant pharmaceuticals from microbial cells: a 2015 update

Sánchez‐García, L., Martín, L., Mangues, R., Ferrer‐Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 341

Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis

Moore, J. H., & Williams, S. M. (2005) · BioEssays · doi:10.1002/bies.20236 · Cited by 341

The switch from fetal to adult hemoglobin.

Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333

Changing patterns in the epidemiology of β‐thalassemia

Kattamis, A., Forni, G. L., Aydınok, Y., & Viprakasit, V. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13512 · Cited by 332

The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening

Xu, X., Zhou, Y., Luo, G., Liao, C., Zhou, M., Chen, P. Y., Lu, J., Jia, S., Xiao, G. F., Shen, X., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014456 · Cited by 326

Robustness, evolvability, and neutrality

Wagner, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.063 · Cited by 325

Thalassemia intermedia: Revisited

Taher, A. T., Isma’eel, H., & Cappellini, M. D. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.04.005 · Cited by 315

Hemoglobin H disease: not necessarily a benign disorder

Chui, D. H. K., Fucharoen, S., & Chan, V. (2003) · Blood · doi:10.1182/blood-2002-07-1975 · Cited by 309

Social Adversity, the Serotonin Transporter (5-HTTLPR) Polymorphism and Major Depressive Disorder

Surtees, P. G., Wainwright, N. W. J., Willis-Owen, S. A. G., Luben, R., Day, N. E., & Flint, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.014 · Cited by 265

Is there a future for TNF promoter polymorphisms?

Bayley, J.-P., Ottenhoff, T. H. M., & Verweij, C. L. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364055 · Cited by 265

3′ end mRNA processing: molecular mechanisms and implications for health and disease

Danckwardt, S., Hentze, M. W., & Kulozik, A. E. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601932 · Cited by 296

Control of fetal hemoglobin: new insights emerging from genomics and clinical implications

Thein, S. L., Menzel, S., Lathrop, M., & Garner, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp401 · Cited by 250

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Vogiatzi, M. G., Macklin, E. A., Fung, E. B., Cheung, A. M., Vichinsky, E. P., Olivieri, N. F., Kirby-Allen, M. A., Kwiatkowski, J. L., Cunningham, M. J., Holm, I. A., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080505 · Cited by 254

Population Stratification of a Common APOBEC Gene Deletion Polymorphism

Kidd, J. M., Newman, T. L., Tüzün, E., Kaul, R., & Eichler, E. E. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030063 · Cited by 253

Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China

Xiong, F., Sun, M., Zhang, X., Cai, R., Zhou, Y., Lou, J., Zeng, L., Sun, Q., Xiao, Q., Shang, X., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01430.x · Cited by 248

Mendelian disorders deserve more attention

Antonarakis, S. E., & Beckmann, J. S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1826 · Cited by 253

Challenges of blood transfusions in β-thalassemia

Shah, F., Sayani, F. A., Trompeter, S., Drašar, E., & Piga, A. G. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100588 · Cited by 236

Race, Ancestry, and Genes: Implications for Defining Disease Risk

Kittles, R. A., & Weiss, K. M. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110356 · Cited by 233

Patterns of Human Diversity, within and among Continents, Inferred from Biallelic DNA PolymorphismsPreprint

Romualdi, C., Balding, D. J., Nasidze, I. S., Risch, G., Robichaux, M. B., Sherry, S. T., Stoneking, M., Batzer, M. A., & Barbujani, G. (2002) · Genome Research · doi:10.1101/gr.214902 · Cited by 226

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction

Yu, C., Niakan, K. K., Matsushita, M. M., Stamatoyannopoulos, G., Orkin, S. H., & Raskind, W. H. (2002) · Blood · doi:10.1182/blood-2002-02-0387 · Cited by 217

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer

Rivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 222

Genotype–Phenotype Correlations in Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease

Rossetti, S., & Harris, P. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010125 · Cited by 215

Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities

Wilber, A. C., Nienhuis, A. W., & Persons, D. A. (2011) · Blood · doi:10.1182/blood-2010-11-316893 · Cited by 226

Advances in the understanding of haemoglobin switching

Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08105.x · Cited by 225

Predicting disease using genomics

Bell, J. I. (2004) · Nature · doi:10.1038/nature02624 · Cited by 215

Optimal management of β thalassaemia intermedia

Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 210

Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia

Ye, L., Wang, J., Tan, Y., Beyer, A. I., Xie, F., Muench, M. O., & Kan, Y. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612075113 · Cited by 197

A genetic profile of contemporary Jewish populations

D, H. O. M. (2001) · Nature Reviews Genetics · doi:10.1038/35098506 · Cited by 187

Pathophysiology and Clinical Manifestations of the -ThalassemiasPreprint

Nienhuis, A. W., & Nathan, D. G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011726 · Cited by 193

Sickle Cell Disease: New Opportunities and Challenges in Africa

Makani, J., Ofori-Acquah, S. F., Nnodu, O. E., Wonkam, A., & Ohene‐Frempong, K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/193252 · Cited by 180

Maneuvering in the Complex Path from Genotype to Phenotype

Strohman, R. C. (2002) · Science · doi:10.1126/science.1070534 · Cited by 176

Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants

Perkins, A. C., Xu, X., Higgs, D. R., Patrinos, G. P., Arnaud, L., Bieker, J. J., Philipsen, S., & Workgroup, T. K. C. (2016) · Blood · doi:10.1182/blood-2016-01-694331 · Cited by 165

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Libani, I. V., Guy, E. C., Melchiori, L., Schirò, R., Ramos, P., Breda, L., Scholzen, T. E., Chadburn, A., Liu, Y., Kernbach, M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-126938 · Cited by 162

Cilia in vertebrate development and disease

Oh, E. C. T., & Katsanis, N. (2012) · Development · doi:10.1242/dev.050054 · Cited by 167

Genetic Variation and Adaptation in Africa: Implications for Human Evolution and DiseasePreprint

Gomez, F., Hirbo, J. B., & Tishkoff, S. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008524 · Cited by 161

A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation

Borgatti, R., Zucca, C., Cavallini, A. R., Ferrario, M., Panzeri, C., Castaldo, P., Soldovieri, M. V., Baschirotto, C., Bresolin, N., Bernardina, B. D., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132979.08394.6d · Cited by 156

Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia

Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 156

KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia

Liu, D., Zhang, X., Yu, L., Cai, R., Ma, X., Zheng, C., Zhou, Y., Liu, Q., Wei, X., Lin, L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-561779 · Cited by 157

Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System

Song, B., Fan, Y., He, W., Zhu, D., Niu, X., Wang, D., Ou, Z., Luo, M., & Sun, X. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0347 · Cited by 154

Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs

Xu, P., Tong, Y., Liu, X., Wang, T., Li, C., Wang, B.-Y., Lv, X., Huang, Y., & Liu, D. (2015) · Scientific Reports · doi:10.1038/srep12065 · Cited by 152

Edgotype: a fundamental link between genotype and phenotype

Sahni, N., Yi, S. S., Zhong, Q., Jailkhani, N., Charloteaux, B., Cusick, M. E., & Vidal, M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.002 · Cited by 150

Molecular Basis and Genetic Modifiers of Thalassemia

Mettananda, S., & Higgs, D. R. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.003 · Cited by 130

Screening for thalassemia

Cao, A., Rosatelli, M. C., Monni, G., & Galanello, R. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(01)00006-7 · Cited by 146

Ineffective Erythropoiesis in β ‐Thalassemia

Ribeil, J., Arlet, J., Dussiot, M., Moura, I. C., Courtois, G., & Hermine, O. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/394295 · Cited by 149

Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids

Kalpravidh, R. W., Siritanaratkul, N., Insain, P., Charoensakdi, R., Panichkul, N., Hatairaktham, S., Srichairatanakool, S., Phisalaphong, C., Rachmilewitz, E. A., & Fucharoen, S. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.10.057 · Cited by 136

-Thalassemia Intermedia: A Clinical PerspectivePreprint

Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013482 · Cited by 134

Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease

Vichinsky, E. P., Macklin, E. A., Waye, J. S., Lorey, F., & Olivieri, N. F. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0843 · Cited by 131

Sickle Cell Disease

Buchanan, G. R., DeBaun, M. R., Quinn, C. T., & Steinberg, M. H. (2004) · Hematology · doi:10.1182/asheducation-2004.1.35 · Cited by 129

Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance

Carta, S., Penco, F., Lavieri, R., Martini, A., Dinarello, C. A., Gattorno, M., & Rubartelli, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424741112 · Cited by 121

Adducin Polymorphism

Bianchi, G., Ferrari, P., & Staessen, J. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000156497.39375.37 · Cited by 124

Prevention of severe thalassemia in northeast Thailand: 16 years of experience at a single university center

Yamsri, S., Sanchaisuriya, K., Fucharoen, G., Sae‐ung, N., Ratanasiri, T., & Fucharoen, S. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2514 · Cited by 124

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118

Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies

Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114

Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis

Winge, M. C. G., Bilcha, K. D., Liedén, A., Shibeshi, D., Sandilands, A., Wahlgren, C., McLean, W. H. I., Nordenskjöld, M., & Bradley, M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10475.x · Cited by 116

Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity

Orfali, K. A., Ohene‐Abuakwa, Y., & Ball, S. E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04890.x · Cited by 116

A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease

Cai, L., Bai, H., Mahairaki, V., Gao, Y., He, C., Wen, Y., Jin, Y.-C., Wang, Y., Pan, R. L., Qasba, A., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0066 · Cited by 111

Studies in haemoglobin E beta‐thalassaemia

Olivieri, N. F., Muraca, G. M., O’Donnell, A., Premawardhena, A., Fisher, C. A., & Weatherall, D. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07126.x · Cited by 109

Update in the genetics of thalassemia: What clinicians need to know

Shang, X., & Xu, X. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.10.012 · Cited by 106

Erythrocyte variants and the nature of their malaria protective effect

Min‐Oo, G., & Gros, P. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00524.x · Cited by 106

Muscular dystrophy into the new millennium

Emery, A. E. H. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00303-0 · Cited by 106

Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with β thalassemia

Viprakasit, V., Tanphaichitr, V. S., Chinchang, W., Sangkla, P., Weiss, M. J., & Higgs, D. R. (2004) · Blood · doi:10.1182/blood-2003-11-3957 · Cited by 105

Heme-regulated eIF2α kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and β-thalassemia

Han, A., Fleming, M. D., & Chen, J.-J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24141 · Cited by 104

Susceptibility to malaria as a complex trait: big pressure from a tiny creature

Fortin, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2469 · Cited by 105

Beyond the Oncogene Paradigm: Understanding Complexity in Cancerogenesis

Bizzarri, M., Cucina, A., Conti, F., & D’Anselmi, F. (2008) · Acta Biotheoretica · doi:10.1007/s10441-008-9047-8 · Cited by 105

α‐Thalassemia: Hb H Disease and Hb Barts Hydrops Fetalis

Chui, D. H. K. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.004 · Cited by 100

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer

Wilber, A. C., Hargrove, P. W., Kim, Y., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 98

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 103

Single-Tube Multiplex-PCR Screen for Anti-3.7 and Anti-4.2 α-Globin Gene Triplications

Wang, W., Ma, E. S. K., Chan, A. Y. Y., Prior, J. F., Erber, W. N., Chan, L. C., Chui, D. H. K., & Chong, S. S. (2003) · Clinical Chemistry · doi:10.1373/49.10.1679 · Cited by 99

Targeted Therapeutic Strategies for Fetal Hemoglobin Induction

Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 102

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 98

The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum

Tiffert, T., Lew, V. L., Ginsburg, H., Krugliak, M., Croisille, L., & Mohandas, N. (2005) · Blood · doi:10.1182/blood-2004-12-4948 · Cited by 91

Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria

Verra, F., Simporè, J., Warimwe, G. M., Tetteh, K. K. A., Howard, T., Osier, F. H. A., Bancone, G., Avellino, P., Blot, I., Fegan, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000978 · Cited by 88

Population Screening for Hemoglobinopathies

Goonasekera, H. W. W., Paththinige, C. S., & Dissanayake, V. H. W. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035451 · Cited by 96

The Present and Future Global Burden of the Inherited Disorders of Hemoglobin

Piel, F. B. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.004 · Cited by 87

Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1α Mutations

Klupa, T., Warram, J. H., Antonellis, A., Pezzolesi, M. G., Nam, M., Malecki, M. T., Doria, A., Rich, S. S., & Królewski, A. S. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2292 · Cited by 86

Base and Prime Editing Technologies for Blood Disorders

Antoniou, P., Miccio, A., & Brusson, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618406 · Cited by 94

The proteomic landscape of genome-wide genetic perturbations

Messner, C. B., Demichev, V., Muenzner, J., Aulakh, S. K., Barthel, N., Röhl, A., Herrera-Domínguez, L., Egger, A.-S., Kamrad, S., Hou, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.026 · Cited by 88

A case for developing North-South partnerships for research in sickle cell disease

Weatherall, D. J., Hofman, K. J., Rodgers, G. P., Ruffin, J., & Hrynkow, S. H. (2004) · Blood · doi:10.1182/blood-2004-06-2404 · Cited by 85

Imprinting of Genes and the Barker Hypothesis

Young, L. E. (2001) · Twin Research · doi:10.1375/1369052012632 · Cited by 84

Thalassaemia: the long road from bedside to genome

Weatherall, D. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1406 · Cited by 81

The Thalassemias: The Role of Molecular Genetics in an Evolving Global Health Problem**Previously presented at the annual meeting of The American Society of Human Genetics, in Los Angeles, on November 7, 2003.

Weatherall, D. J. (2004) · The American Journal of Human Genetics · doi:10.1086/381402 · Cited by 81

Mendelian disorders and multifactorial traits: the big divide or one for all?

Antonarakis, S. E., Chakravarti, A., Cohen, J. C., & Hardy, J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2793 · Cited by 85

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia

Fisher, S. A., Brunskill, S. J., Doree, C. J., Gooding, S., Chowdhury, O., & Roberts, D. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004450.pub3 · Cited by 79

Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression

Antoniou, P., Hardouin, G., Martinucci, P., Frati, G., Félix, T., Chalumeau, A., Fontana, L., Martin, J., Masson, C., Brusson, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34493-1 · Cited by 85

Molecular Basis and Genetic Modifiers of Thalassemia

Tesio, N., & Bauer, D. E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.001 · Cited by 91

Guidelines for Diagnosis and Management of Beta-Thalassemia Intermedia

Karimi, M., Cohan, N., Sanctis, V. D., Mallat, N. S., & Taher, A. T. (2014) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2014.937884 · Cited by 78

Exploring genetic modifiers of Gaucher disease: The next horizon

Davidson, B. A., Hassan, S., Garcia, E. J., Tayebi, N., & Sidransky, E. (2018) · Human Mutation · doi:10.1002/humu.23611 · Cited by 79

Complex genetic control of susceptibility to malaria in mice

Fortin, A., Stevenson, M. M., & Gros, P. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363841 · Cited by 80

Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus

Min‐Oo, G., Fortin, A., Pitari, G., Tam, M., Stevenson, M. M., & Gros, P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061252 · Cited by 77

β-Thalassaemia prototype of a single gene disorder with multiple phenotypes

Thein, S. L. (2002) · International Journal of Hematology · doi:10.1007/bf03165097 · Cited by 11

The phenotypic diversity of monogenic disease: lessons from the thalassemias.

Weatherall, D. J. (1998) · PubMed · Cited by 6

Genetic modifiers of beta-thalassemia.

Thein, S. L. (2005) · PubMed · Cited by 188

Beta Globin Gene and Related Diseases: A Review

Das, S. K., & Talukder, G. (2002) · International Journal of Human Genetics · doi:10.1080/09723757.2002.11885798 · Cited by 12

3 β-Thalassaemia

Thein, S. L. (1998) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(98)80071-1 · Cited by 57